内镜黏膜下剥离术用于临床黏膜下浸润性早期胃癌的可能性探讨
结论提示术前内镜病变大小、部位、组织学和大体类型应考虑用于cT1b早期胃癌治疗方式的选择。
要点
- ESD合格组内镜病变倾向于小于20 mm且位于胃远端。
- 内镜活检高分化管状腺癌及平坦/凹陷型与ESD合格相关。
核心结论
- 术前内镜病变大小、部位、组织学和大体类型应考虑用于cT1b早期胃癌治疗方式的选择。
研究设计与样本
- 按最终手术病理结果分为ESD合格组(n=203)与ESD不合格组(n=261),比较术前临床特征。
主要发现
- ESD合格组内镜病变倾向于小于20 mm且位于胃远端。
- ESD合格组内镜活检高分化管状腺癌比例显著更高。
- ESD合格组内镜评估为平坦/凹陷型的比例显著更高。
关键数值与推荐
- ESD合格组定义为最终手术病理结果符合当前ESD适应证。
- ESD不合格组定义为最终手术病理结果不符合当前ESD适应证。
- 纳入标准为cT1b早期胃癌、肿瘤直径≤30 mm、分化型组织学。
临床怎么用
- 对cT1b早期胃癌选择治疗方式时,应综合评估内镜病变大小、部位、组织学和大体类型。
- 内镜病变小于20 mm、位于胃远端、活检高分化管状腺癌及平坦/凹陷型者,可考虑ESD保留胃的可能性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The current standard treatment modality for clinical submucosal invasive (cT1b) early gastric cancer (EGC) is surgery. However, there are discrepancies in T staging between pre- and post-operative findings, and in cases of overestimation, patients may lose the opportunity to preserve the stomach. The aim of this study was to analyze surgical outcomes of cT1b EGC and determine the pre-treatment factors favoring ESD. METHODS: Patients who underwent gastrectomy for cT1b EGC with a tumor size of 30 mm or less in diameter and differentiated-type histology were retrospectively reviewed from January 2010 to December 2014. According to the final surgical pathologic results, two groups were classified: patients whose pathologic results qualified for current ESD indication (ESD-qualified group, n = 203) and patients whose pathologic results made them ineligible for ESD (ESD-disqualified group, n = 261). The preoperative clinical characteristics were compared. RESULTS: Forty-three percent of the patients (203/464) who underwent gastrectomy for cT1b EGC qualified for ESD; their endoscopic lesion tended to be smaller than 20 mm in size and located in the distal part of stomach. In addition, the ESD-qualified group showed a significantly higher proportion of well-differentiated tubular adenocarcinoma on endoscopic biopsy and of the flat/depressed type in the endoscopic evaluation. CONCLUSION: Forty-three percent of the patients with cT1b EGC who underwent gastrectomy had a chance to preserve their stomach by ESD. Therefore, pre-treatment factors such as endoscopic lesion size, location, histology, and gross type should be considered for treatment modality selection for cT1b EGC.
引用
- Lee HD, Chung H, Kim SG, et al. Exploring the possibility of endoscopic submucosal dissection for clinical submucosal invasive early gastric cancers. Surg Endosc. 2019. PMID: 30725253. doi:10.1007/s00464-019-06690-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。